Therapeutic Asset Ratings

303 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
ETOPOSIDE Prostate Adenocarcinoma	University of Washington	P2	CCC (53)
Fedratinib Essential Thrombocythemia	University of Washington	P2	CCC (53)
Fedratinib Myelodysplastic/Myeloproliferative Neoplasm	University of Washington	P2	CCC (53)
Fedratinib Myeloproliferative Neoplasm	University of Washington	P2	CCC (53)
Fedratinib Myeloproliferative Neoplasm, Unclassifiable	University of Washington	P2	CCC (53)
Fedratinib Acquired Polycythemia Vera	University of Washington	P2	CCC (53)
Fedratinib Primary Myelofibrosis	University of Washington	P2	CCC (53)
Fedratinib Myelofibrosis	University of Washington	P2	CCC (53)
FES F-18 Her2-Receptor Negative Breast Cancer	University of Washington	P2	CCC (53)
FES F-18 Hormone Receptor-Positive Breast Cancer	University of Washington	P2	CCC (53)
FFNP Her2-Receptor Negative Breast Cancer	University of Washington	P2	CCC (53)
FFNP Hormone Receptor-Positive Breast Cancer	University of Washington	P2	CCC (53)
FILGRASTIM B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	University of Washington	P2	CCC (53)
FLUDEOXYGLUCOSE Burkitt Lymphoma	University of Washington	P2	CCC (53)
FLUDEOXYGLUCOSE Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly	University of Washington	P2	CCC (53)
FLUDEOXYGLUCOSE Estrogen-Receptor Positive Breast Cancer	University of Washington	P2	CCC (53)
FLUDEOXYGLUCOSE High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement	University of Washington	P2	CCC (53)
FLUDEOXYGLUCOSE Hormone Receptor-Positive Breast Cancer	University of Washington	P2	CCC (53)
FLUDEOXYGLUCOSE Primary Mediastinal Large B-Cell Lymphoma	University of Washington	P2	CCC (53)
FLUDEOXYGLUCOSE T-Cell/Histiocyte Rich Large B Cell Lymphoma	University of Washington	P2	CCC (53)
FLUDEOXYGLUCOSE B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma	University of Washington	P2	CCC (53)
Golimumab Castration-Resistant Prostate Carcinoma	University of Washington	P2	CCC (53)
Golimumab Prostate Cancer	University of Washington	P2	CCC (53)
Inno-206 B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	University of Washington	P2	CCC (53)
mln9708 Lymphoplasmacytic Lymphoma	University of Washington	P2	CCC (53)

Showing 176 to 200 of 303 assets

PreviousPage 8 of 13Next